Ghent University Academic Bibliography

Show Sort by

Your filters: cql: author="Antonenkova, Natalia N" or (type exact bookEditor and editor="Antonenkova, Natalia N")

Add to list
- Journal Article
- A1
- open access
The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer

Gisella Figlioli, Massimo Bogliolo, Irene Catucci, Laura Caleca, Sandra Viz Lasheras, Roser Pujol, Johanna I Kiiski, Taru A Muranen, Daniel R Barnes, Joe Dennis, et al.

(2019) NPJ BREAST CANCER. 5.
Add to list
- Journal Article
- A1
- open access
Shared heritability and functional enrichment across six solid cancers

Xia Jiang, Hilary K Finucane, Fredrick R Schumacher, Stephanie L Schmit, Jonathan P Tyrer, Younghun Han, Kyriaki Michailidou, Corina Lesseur, Karoline B Kuchenbaecker, Joe Dennis, et al.

(2019) NATURE COMMUNICATIONS. 10.
Add to list
- Journal Article
- A1
- open access
Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer

Roger L Milne, Karoline B Kuchenbaecker, Kyriaki Michailidou, Jonathan Beesley, Siddhartha Kar, Sara Lindström, Shirley Hui, Audrey Lemaçon, Penny Soucy, Joe Dennis, et al.

(2017) NATURE GENETICS. 49(12). p.1767-1778
Add to list
- Journal Article
- A1
- open access
PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS

Melissa Southey, David E Goldgar, Robert Winqvist, Katri Pylkäs, Fergus Couch, Marc Tischkowitz, William D Foulkes, Joe Dennis, Kyriaki Michailidou, Elizabeth J van Rensburg, et al.

(2016) JOURNAL OF MEDICAL GENETICS. 53(12). p.800-811
Add to list
No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer

Antoinette Hollestelle, Frederieke H van der Baan, Andrew Berchuck, Sharon E Johnatty, Katja K Aben, Bjarni A Agnarsson, Kristiina Aittomäki, Elisa Alducci, Irene L Andrulis, Hoda Anton-Culver, et al.

(2016) GYNECOLOGIC ONCOLOGY. 141(2). p.386-401

Academic Bibliography

The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer

Shared heritability and functional enrichment across six solid cancers

Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer

PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS

No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer

Contents

Support

Contact